PURPOSE: To assess the clinical phenotype in a Swedish family with X- linked retinitis pigmentosa (XLRP) resulting from a novel splice defect in the RPGR gene. METHODS: RPGR mutation analysis was performed in one family with XLRP, and several individuals from the family were examined clinically. RESULTS: The causative mutation in the family was demonstrated to be a single base-pair change at the splice donor site in intron 7 that resulted in skipping of the complete exon 7 in the mature RPGR transcript. The aberrant mRNA is predicted to produce an RPGR protein with an in-frame deletion of 53 amino acids, corresponding to an RCC1-homology repeat. Clinical studies that included ophthalmological examination and full-field electroretinography s...
The goal of the study was to explore the spectrum of pathogenic variants in the RPGR gene in a group...
X-linked forms of retinitis pigmentosa (XLRP) are among the most severe because of their early onset...
X-linked retinitis pigmentosa (XLRP) is a clinically and genetically heterogeneous degenerative dise...
PURPOSE: To assess the clinical phenotypes in three Swedish families with X-linked retinitis pigment...
Purpose: To identify novel mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene and re...
PURPOSE: To describe new disease-causing RP2 and RPGR-ORF15 mutations and their corresponding clinic...
Contains fulltext : 89365.pdf (publisher's version ) (Closed access)PURPOSE: The m...
Importance: Pathogenic variants in retinitis pigmentosa GTPase regulator (RPGR) gene typically lead ...
SummaryThe RPGR (retinitis pigmentosa GTPase regulator) gene for RP3, the most frequent genetic subt...
PURPOSE: The goal of this study was to identify mutations in X-chromosomal genes associated with ret...
PURPOSE: The goal of this study was to identify mutations in X-chromosomal genes associated with ret...
The RPGR (retinitis pigmentosa GTPase regulator) gene has been shown to be mutated in 10-20% of pati...
X-linked retinitis pigmentosa (XLRP) is a severe form of inherited progressive retinal degeneration....
PURPOSE: A comprehensive screening was conducted for RP2 and retinitis pigmentosa GTPase regulator (...
AIM: To report a novel splicing mutation in the RPGR gene (encoding retinitis pigmentosa GTPase regu...
The goal of the study was to explore the spectrum of pathogenic variants in the RPGR gene in a group...
X-linked forms of retinitis pigmentosa (XLRP) are among the most severe because of their early onset...
X-linked retinitis pigmentosa (XLRP) is a clinically and genetically heterogeneous degenerative dise...
PURPOSE: To assess the clinical phenotypes in three Swedish families with X-linked retinitis pigment...
Purpose: To identify novel mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene and re...
PURPOSE: To describe new disease-causing RP2 and RPGR-ORF15 mutations and their corresponding clinic...
Contains fulltext : 89365.pdf (publisher's version ) (Closed access)PURPOSE: The m...
Importance: Pathogenic variants in retinitis pigmentosa GTPase regulator (RPGR) gene typically lead ...
SummaryThe RPGR (retinitis pigmentosa GTPase regulator) gene for RP3, the most frequent genetic subt...
PURPOSE: The goal of this study was to identify mutations in X-chromosomal genes associated with ret...
PURPOSE: The goal of this study was to identify mutations in X-chromosomal genes associated with ret...
The RPGR (retinitis pigmentosa GTPase regulator) gene has been shown to be mutated in 10-20% of pati...
X-linked retinitis pigmentosa (XLRP) is a severe form of inherited progressive retinal degeneration....
PURPOSE: A comprehensive screening was conducted for RP2 and retinitis pigmentosa GTPase regulator (...
AIM: To report a novel splicing mutation in the RPGR gene (encoding retinitis pigmentosa GTPase regu...
The goal of the study was to explore the spectrum of pathogenic variants in the RPGR gene in a group...
X-linked forms of retinitis pigmentosa (XLRP) are among the most severe because of their early onset...
X-linked retinitis pigmentosa (XLRP) is a clinically and genetically heterogeneous degenerative dise...